La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su del período menstrual debe suspenderse el fármaco y confirmar el embarazo. Publisher: Cabergolina y bromocriptina son los fármacos más utilizados probablemente aumenta la probabilidad de embarazo, y se asocia a. El uso de cabergolina no afecta el resultado de embarazo (tasa de embarazo clínico, tasa de aborto espontáneo), ni existe un aumento en el riesgo de eventos .

Author: Meztikree Akinolkis
Country: Saint Lucia
Language: English (Spanish)
Genre: Spiritual
Published (Last): 15 November 2015
Pages: 246
PDF File Size: 2.10 Mb
ePub File Size: 4.32 Mb
ISBN: 287-6-42803-501-3
Downloads: 51353
Price: Free* [*Free Regsitration Required]
Uploader: JoJolar

Comparative effects of bromocriptine and cabergoline cabergolins serum prolactin levels, liver and kidney function tests in hyperprolactinemic women. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: La bromocriptina se asocia a mayores efectos adversos que cabergolina. Pakistan Journal of Medical Sciences Online. Cabergoline is a long-acting dopamine receptor agonist which might offer advantages over bromocriptine.

Medwave se preocupa por su privacidad y la seguridad de sus datos personales.

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Sobre los desenlaces incluidos en este resumen.

Cabergoline or bromocriptine for prolactinoma?

Cabergoline and bromocriptine are among the most commonly used drugs to treat prolactinoma. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.

Cabergoline Comparative Study Group. It is not clear whether cabergoline is also more effective with respect embrazo tumor growth because the certainty of the evidence is very low.

TOP Related  FLUKE 1653B PDF

However, it is not clear if this translates into clinical benefits. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: Comparison of the effects of cabergoline and bromocriptine in women with hyperprolactinemic amenorrhea. Hay cabergoolina de que la lactancia materna no presenta mayor riesgo para el crecimiento tumoral. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.

In general, it is recommended that fetal exposure to all drugs be limited to as short a period as possible. Both, bromocriptine and cabergoline, showed no evidence of obstetric and neonatal complications; however, experience with bromocriptine is higher.

їCabergolina o bromocriptina para el prolactinoma? – Medwave

In microprolactinomas the ophthalmologic examination is no formal indication. N Engl J Med. There is evidence that breastfeeding no increased risk for tumor growth. Todos los estudios compararon bromocriptina versus cabergolina.

The prolactinomas are embaraso most common functioning pituitary tumors. The hyperprolactinemia is associated with anovulation and infertility. If growth in the adenoma is suspected, nuclear magnetic resonance and neuro-ophthalmologic examination should be performed. Por lo tanto, parte de la evidencia incluida en este resumen no fue considerada. Cabergolina versus bromocriptina para la hiperprolactinemia o prolactinoma. Middle East Fertility Society Journal.

Cabergoline currently suggested rather than bromocriptine due to their excellent tolerability and long half-life. Osteocalcin levels in patients with microprolactinoma cqbergolina and during medical treatment.

Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: Results of a national multicenter randomized double-blind study].



Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified two systematic reviews including 12 studies addressing the question of this article, including five randomized controlled trials. Diagnosis and treatment of yperprolactinemia: Su principal desarrollo es la base de datos Epistemonikos www.

The patients with macroprolactinomas should be monitored clinically and evaluate the symptoms related to increased tumor size. Indian J Med Res. La cabergolina se sugiere actualmente en lugar de bromocriptina, debido a su excelente tolerabilidad y prolongada vida media.

In the absence of menstrual period, cabregolina drug should be discontinued and confirm pregnancy. J Clin Endocrinol Metab. De los estudios no aleatorizados incluidos, los tres corresponden a cohortes retrospectivas. Primary medical therapy of micro- and macroprolactinomas in men.

Para un estudio no se especifican dosis de cabergolina y bromocriptina en ninguna de las revisiones identificadas [11]. We combined the evidence using meta-analysis and generated cabergolia summary of findings following the GRADE approach. Cabergoline or bromocriptine for prolactinoma?.